Medidata Study Experience

  1. Characterizing The Use Of External Controls For Augmenting Randomized Control Arms And Confirming Benefit 4/19/2022

    Learn several approaches to constructing an external control while considering the use of hybrid designs that supplement or augment the control group in the randomized control trials (RCT) with data from an external population.

  2. Stronger Data. Smarter Decisions 4/18/2022

    Learn how strong data and strong analytics can help companies design and run better trials during the most complex clinical trial landscape in history.

  3. Characteristics Of A Scalable Real-World And Clinical Trial Data Linkage Solution 3/16/2022

    In this blog, explore how data linkage is a cutting-edge innovation that unlocks a new frontier of enhanced evidence generation by linking clinical trial data (CTD) with real-world data (RWD) at the patient level.

  4. Best Practices For Gaining Stakeholder Buy-In For Data Linkage In Clinical Trials 3/16/2022

    Data linkage methodologies bridge the gaps between clinical trial data (CTD) and real-world data (RWD). However, while the value of data linkage may be apparent to some, gaining patient, investigator, and internal organizational buy-in presents a barrier to evangelizing and championing data linkage.